FDA Approves Amgen's Prolia (Denosumab) for Treatment of Postmenopausal Women With Osteoporosis at High Risk for Fracture
Links shared publicly online about this topic.
- 1,122total visits
FDA Approves Amgen's Prolia (Denosumab) for Treatment of Postmenopausal Women With Osteoporosis at High Risk for Fracture
View full resource at drugs.com
Tags: Emergency, Fracture, Osteoporosis, Osteoporosis Medication, Women's Health, FDA, Prolia, Amgen
Most Recently Shared on June 2, 2010 at 11:55 pm By:
FDA Approves Prolia (denosumab) for Treatment of Postmenopausal Women With Osteoporosis - http://bit.ly/aF8OQu
FDA Approves Amgen's Prolia(TM) (Denosumab) For Treatment Of Postmenopausal Women With Osteoporosis At High Risk For Fracture
medicalnewstoday.com — “Amgen Inc. (Nasdaq: AMGN) announced that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women with osteoporosis at high ris” View full resource at medicalnewstoday.com
Most Recently Shared on August 8, 2010 at 11:36 am By:
Women's Health Line Health Site
FDA Approves Amgen's Prolia(TM) (Denosumab) For Treatment Of Postmenopausal Women With Osteoporosis At... http://sns.ly/zJe48 #womenshealth
Prolia approved for postmenopausal osteoporosis - MPR
empr.com — “The FDA has approved Prolia (denosumab, from Amgen) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.” View full resource at empr.com
Most Recently Shared on June 2, 2010 at 3:36 pm By:
Prolia approved for postmenopausal osteoporosis: The FDA has approved Prolia (denosumab, from Amgen) for the treat... http://bit.ly/cUXDUl
Prolia approved for postmenopausal osteoporosis - MPR
empr.com — “The FDA has approved Prolia (denosumab, from Amgen) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.” View full resource at empr.com
Most Recently Shared on June 2, 2010 at 3:17 pm By:
MPR News: Prolia approved for postmenopausal osteoporosis: The FDA has approved Prolia (denosumab, from Amgen) for... http://bit.ly/a0ZOXp
Prolia approved for postmenopausal osteoporosis - ONA
oncologynurseadvisor.com — “The FDA has approved Prolia (denosumab, from Amgen) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 2, 2010 at 3:00 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Prolia approved for postmenopausal osteoporosis http://goo.gl/fb/bGLvd
Advertisement
